HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emerge Labs Plucks Apple From Tree Of Life? Firm Unveils Stem Cell Serum

This article was originally published in The Rose Sheet

Executive Summary

Emerge Labs has turned to stem cells from a rare Swiss apple with outstanding storage properties for its new serum said to protect the skin against stress, "decreasing wrinkles and producing younger, fresher-looking skin," according to a recent release

You may also be interested in...



Adore Settles With Nationwide Class Over Apple Stem Cell Anti-Aging Claims

The estimated $700,000 settlement puts to rest allegations that the luxury skin-care firm deceived consumers with claims about its PhytoCellTec ingredient’s ability to slow the aging process. G.M. Collin, another PhytoCellTec Malus Domestica user, also appears to have reached a deal with plaintiffs in litigation challenging its anti-aging claims.

Cosmeceutical Actives Span Price Points As Functional Product Demand Grows

Consumers wanting “visible results” increase demand for higher-end cosmeceutical actives once predominantly exclusive to luxury products. Actives like vitamins, collagen and plant stem cells now are appearing in more affordable product formulations.

Cosmeceutical Actives Span Price Points As Functional Product Demand Grows

Consumers wanting “visible results” increase demand for higher-end cosmeceutical actives once predominantly exclusive to luxury products. Actives like vitamins, collagen and plant stem cells now are appearing in more affordable product formulations.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel